Semax
Public supplier report and marketplace listing from Sulan Bio.
Supplier testing information
99.497% purity — independently analysed
Sulan Bio Semax batch SUL0330-001 was independently analysed by Janoshik Laboratory under task #150603.
The analytical report recorded 99.497% purity and 10.32mg measured content for the submitted 10mg sample, providing batch-specific analytical documentation for this marketplace listing.
What is Semax?
Semax is a synthetic neuropeptide developed from a short fragment of adrenocorticotropic hormone (ACTH 4-7), with additional amino acids incorporated to produce the Semax peptide sequence.
It is primarily investigated in experimental neuroscience because of research into its interactions with neurotrophic, neuronal signalling and cellular stress-response pathways rather than the endocrine activity normally associated with full-length ACTH.
Common research areas
Semax is commonly investigated in laboratory and neuroscience research examining:
- Neurotrophic signalling pathways
- BDNF-related signalling and expression
- Neuronal plasticity and synaptic processes
- Learning, memory and cognitive processes in experimental models
- Neuronal stress-response mechanisms
- Oxidative-stress and cellular-response pathways
- Neuroprotective mechanisms in experimental models
- Neuropeptide signalling within the central nervous system
Semax and neurotrophic signalling research
A significant area of experimental Semax research concerns neurotrophic signalling, including pathways associated with brain-derived neurotrophic factor (BDNF).
Neurotrophic factors participate in neuronal survival, synaptic plasticity and adaptive responses within the nervous system. This has made Semax relevant to laboratory models examining how peptide signalling may influence neuronal plasticity and cellular responses to neurological stress.
Available configurations
- 5mg: 10 vials per box
- 10mg: 10 vials per box
- MOQ: 10 vials / 1 box
- Format: Lyophilized research peptide
- Supplier: Sulan Bio
Batch verification
- Supplier: Sulan Bio
- Batch: SUL0330-001
- Reported purity: 99.497%
- Measured content: 10.32mg
- Tested strength: 10mg
- Independent laboratory: Janoshik
- Task number: #150603
- Tested: 21 APR 2026
- COA status: Available
This product is supplied strictly for laboratory research and analytical applications. It is not intended for human consumption, medical use, diagnostic use or clinical application.
Semax laboratory testing questions
What is this Semax report?
This report contains publicly accessible batch testing information for Semax, including task number #150603, reported purity results, and Janoshik-linked laboratory reference data.
Has this Semax batch been laboratory tested?
Yes. This Semax batch includes publicly accessible laboratory testing references, including reported purity result 99.497%, task number #150603, and laboratory reference key I3NPT866NL9F.
Who supplied this Semax batch?
Sulan Bio supplied this Semax batch from China, with public batch testing references and tracked supplier fulfilment information.
What purity was reported for this Semax batch?
The reported purity result for this Semax batch was 99.497%.
Where can I view additional Semax reports?
Additional Semax laboratory testing reports and supplier batch references can be viewed through the Buy China Peptides reports directory.